Latest Dilution News

Peregrine Gold has secured $2.25 million through a discounted placement backed by major shareholder Mark Creasy, Lion Selection Group and company directors. The funding is earmarked for maiden drilling and broader gold and iron ore exploration in Western Australia, subject to heritage and Programme of Work approvals.

Osmond Resources’ preliminary study has put a US$2.31 billion post-tax NPV on its Spanish rare earths and mineral sands project, but the headline economics rest on a scoping-level model and a US$300 million funding requirement. The next test is whether drilling, metallurgy, permitting and financing can turn the attractive concept into a financeable mine.

Artrya has signed a five-year agreement with Huntsville Hospital Health System, converting the first participant in its SAPPHIRE Study into a commercial customer. The deal carries a minimum contracted value of US$0.5 million for Salix Coronary Anatomy, with further usage-based revenue possible from other modules.

Felix Group Holdings has opened a non-underwritten share purchase plan seeking up to A$1 million from eligible Australian and New Zealand shareholders at A$0.038 per share. The offer gives investors access to the same price paid under the institutional placement, but leaves the final amount raised and any scale-back uncertain.

First Au will acquire six exploration licences in Western Australia’s Ora Banda district for A$150,000 upfront, with a further A$500,000 deferred at the seller’s discretion. The deal expands its Riverina tenure but comes with a A$250,000 drilling commitment and remains subject to completion conditions.

Promisia Healthcare has completed its acquisition of Chatswood Retirement Village after receiving shareholder approval in August. The vendors were paid through the issue of 1 million ordinary shares and 1 million unquoted convertible notes, leaving key transaction terms to be assessed in future disclosures.

Chilwa Minerals has lodged a prospectus supporting a fully underwritten US$3.5 million Nasdaq IPO, with most of the proceeds earmarked for exploration at its Chilwa Critical Minerals Project. The raising would strengthen its cash position, but the prospectus also flags material going-concern uncertainty and further funding needs.

BSA is proposing to acquire aerial infrastructure technology business Eonetics in a largely scrip-based transaction that would leave the sellers with about 39.9% of BSA. The deal remains non-binding, with one seller yet to sign and multiple approvals still required.

Xamble has appointed Adrian Tan permanent CEO and elevated Georg Johann Chmiel to chair as it seeks to convert recent operating improvements into sustained growth. Ganesh Kumar Bangah is stepping down from the board to take a senior Malaysian government-linked role but will remain involved as an adviser and substantial shareholder.

Nutritional Growth Solutions has completed its acquisition of Sprout Organic, installing founder Selasi Berdie as CEO and reshaping the group around infant, toddler and children’s nutrition. The deal lifts shares on issue to 964 million, while management targets A$870,000 in annualised savings.

Stakk Limited (ASX:SKK) delivered a sharp FY2026 revenue increase and moved to audited operating profitability, but its next test is considerably larger: integrating ParaScript while servicing new debt and converting contracted revenue into cash. The company is targeting A$55.2 million of pro forma revenue and A$18.5 million of EBITDA in FY2027.

Transurban Group has agreed to pay $4.5 billion for Canada’s pension fund’s stakes in three major Sydney toll roads, lifting its ownership of Westlink M7, NorthConnex and WestConnex. The debt-funded transaction is expected to support long-term free cash growth, but still requires regulatory and contractual approvals.